BeiGene is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter) and Facebook.

Website: http://www.beigene.com

Employees: 4244

HQ: (628) 239-0467

Location: Cambridge, Massachusetts, US

Revenue: $877 million

BeiGene, a biotechnology company, is a global leader in the development and commercialization of innovative cancer therapies. With a focus on precision medicine, BeiGene's products have shown significant promise in treating various types of cancer. If you're looking for contact information for BeiGene, ConnectPlex is the right place to be. Our platform offers a comprehensive database of company information, including contact details for key personnel at BeiGene. Reach out to us today and connect with the right people to take your business forward. At ConnectPlex, we understand the importance of accurate and up-to-date contact information. That's why we've developed a robust system that ensures our data is constantly updated and verified. When you search for 'contact details for BeiGene' on our platform, you can be sure that you'll get the most reliable and relevant results. Whether you're looking to collaborate with BeiGene or explore business opportunities, ConnectPlex is your go-to resource for all your lead generation needs.

BeiGene is a global biotechnology company that focuses on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of over 40 clinical candidates, the company expedites the development of its diverse pipeline of novel therapeutics through its own capabilities and collaborations. BeiGene has a growing global team of more than 8,000 colleagues across five continents, with headquarters located in Cambridge, Mass., Basel, and Beijing. The company's focus on targeted therapy and immuno-oncology has led to the development of several promising drugs, including its flagship product, tislelizumab, which is being studied in various cancer indications. BeiGene's commitment to affordability and access has resulted in partnerships with leading healthcare organizations and governments, ensuring that its medicines reach patients who need them most. BeiGene's strong leadership team, including Julia Wang, Deputy Chief Financial Officer, and Michael Schoen, Chief of Staff to the CEO and SVP of Business Operations, has played a crucial role in the company's success. The company's focus on innovation, affordability, and access has positioned it as a leader in the biotechnology industry, with a revenue of $100-500 million and a market capitalization of over $10 billion. In conclusion, BeiGene's mission to develop innovative and affordable medicines has the potential to transform the lives of millions of patients worldwide. With its strong leadership, diverse pipeline, and commitment to access, BeiGene is poised for continued success in the biotechnology industry.

BeiGene is a biotech company that works worldwide to make new and affordable medicines. They want to help patients get better treatment. They have many different medicines being developed and work with other companies to make them. BeiGene has a lot of employees all over the world and has offices in Cambridge, Basel, and Beijing. You can learn more about them by visiting their website or following them on Twitter.